| 000 | 01656 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250515193526.0 | ||
| 264 | 0 | _c20100511 | |
| 008 | 201005s 0 0 eng d | ||
| 022 | _a1365-2036 | ||
| 024 | 7 |
_a10.1111/j.1365-2036.2009.04194.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCelasco, G | |
| 245 | 0 | 0 |
_aClinical trial: oral colon-release parnaparin sodium tablets (CB-01-05 MMX) for active left-sided ulcerative colitis. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cFeb 2010 |
||
| 300 |
_a375-86 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnticoagulants _xadministration & dosage |
| 650 | 0 | 4 |
_aColitis, Ulcerative _xdrug therapy |
| 650 | 0 | 4 |
_aColon _xdrug effects |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeparin, Low-Molecular-Weight _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aPapa, A | |
| 700 | 1 | _aJones, R | |
| 700 | 1 | _aMoro, L | |
| 700 | 1 | _aBozzella, R | |
| 700 | 1 | _aSurace, M M | |
| 700 | 1 | _aNaccari, G C | |
| 700 | 1 | _aGasbarrini, G | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 31 _gno. 3 _gp. 375-86 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2036.2009.04194.x _zAvailable from publisher's website |
| 999 |
_c19279638 _d19279638 |
||